GB2296495B - Anthracycline derivatives - Google Patents

Anthracycline derivatives

Info

Publication number
GB2296495B
GB2296495B GB9426075A GB9426075A GB2296495B GB 2296495 B GB2296495 B GB 2296495B GB 9426075 A GB9426075 A GB 9426075A GB 9426075 A GB9426075 A GB 9426075A GB 2296495 B GB2296495 B GB 2296495B
Authority
GB
United Kingdom
Prior art keywords
anthracycline derivatives
anthracycline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9426075A
Other versions
GB9426075D0 (en
GB2296495A (en
Inventor
Michele Caruso
Alberto Bargiotti
Cristina Geroni
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA, Pharmacia SpA filed Critical Farmitalia Carlo Erba SRL
Priority to GB9426075A priority Critical patent/GB2296495B/en
Publication of GB9426075D0 publication Critical patent/GB9426075D0/en
Priority to IT95MI002614A priority patent/IT1277073B1/en
Priority to DE19547958.0A priority patent/DE19547958B4/en
Priority to JP33521695A priority patent/JP4081148B2/en
Publication of GB2296495A publication Critical patent/GB2296495A/en
Application granted granted Critical
Publication of GB2296495B publication Critical patent/GB2296495B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
GB9426075A 1994-12-23 1994-12-23 Anthracycline derivatives Expired - Lifetime GB2296495B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9426075A GB2296495B (en) 1994-12-23 1994-12-23 Anthracycline derivatives
IT95MI002614A IT1277073B1 (en) 1994-12-23 1995-12-13 ANTHRACYCLINIC DERIVATIVES
DE19547958.0A DE19547958B4 (en) 1994-12-23 1995-12-21 Anthracycline derivatives
JP33521695A JP4081148B2 (en) 1994-12-23 1995-12-22 Anthracycline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9426075A GB2296495B (en) 1994-12-23 1994-12-23 Anthracycline derivatives

Publications (3)

Publication Number Publication Date
GB9426075D0 GB9426075D0 (en) 1995-02-22
GB2296495A GB2296495A (en) 1996-07-03
GB2296495B true GB2296495B (en) 1998-04-15

Family

ID=10766488

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9426075A Expired - Lifetime GB2296495B (en) 1994-12-23 1994-12-23 Anthracycline derivatives

Country Status (4)

Country Link
JP (1) JP4081148B2 (en)
DE (1) DE19547958B4 (en)
GB (1) GB2296495B (en)
IT (1) IT1277073B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021031599A1 (en) * 2019-08-22 2021-02-25 联宁（苏州）生物制药有限公司 Method for preparing drug toxin pnu-159682 of antibody drug conjugate, and intermediate therein

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315067B (en) * 1996-07-11 2000-02-16 Pharmacia Spa Morpholinyl anthracycline derivatives
AU767394C (en) * 1999-12-29 2005-04-21 Immunogen, Inc. Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
BRPI0408494A (en) * 2003-03-18 2006-04-04 Pharmacia Italia Spa combined tumor therapy comprising nemorubicin with radiation therapy
AU2004222527A1 (en) * 2003-03-18 2004-09-30 Pharmacia Italia Spa Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
ES2547552T3 (en) 2008-02-01 2015-10-07 Genentech, Inc. Nemorubicin metabolite and similar reagents, antibody-drug conjugates and methods
EP2277884B1 (en) 2008-04-11 2017-08-23 Tianjin Hemay Oncology Pharmaceutical Co., Ltd Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof
BRPI0911647A2 (en) * 2008-04-11 2015-10-13 Tianjin Hemay Bio Tech Co Ltd compounds with high activity anthracycline antibiotics, preparation methods and their use.
AU2009270988A1 (en) 2008-07-15 2010-01-21 Genentech, Inc. Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
RU2563638C2 (en) 2010-12-02 2015-09-20 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Method of obtaining morpholinylanthracycline derivatives
ES2633359T3 (en) * 2012-03-06 2017-09-20 Tianjin Hemay Oncology Pharmaceutical Co., Ltd. Tetracyclic anthraquinone derivatives
ES2695162T3 (en) * 2013-04-29 2019-01-02 Nerviano Medical Sciences Srl New derivatives of morpholinyl anthracycline
JP6785780B2 (en) 2014-11-05 2020-11-18 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ Functionalized morpholinyl anthracycline derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301277A (en) * 1980-10-20 1981-11-17 Sri International 3-Deamino-3-(4-morpholinyl) derivatives of daunorubicin and doxorubicin
JPS57163393A (en) * 1981-03-27 1982-10-07 Microbial Chem Res Found Novel anthracyclin derivative and its preparation
JPS59212499A (en) * 1983-05-13 1984-12-01 アドリヤ・ラボラトリ−ズ・インコ−ポレ−テツド 4-demethoxy-3'-deamino-3'(4-morpholinyl) derivative
US4585859A (en) * 1983-05-24 1986-04-29 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021031599A1 (en) * 2019-08-22 2021-02-25 联宁（苏州）生物制药有限公司 Method for preparing drug toxin pnu-159682 of antibody drug conjugate, and intermediate therein
AU2020333565B2 (en) * 2019-08-22 2022-07-21 Levena Biopharma Co., Ltd. Method for preparing drug toxin PNU-159682 of antibody drug conjugate, and intermediate therein

Also Published As

Publication number Publication date
DE19547958A1 (en) 1996-06-27
DE19547958B4 (en) 2015-01-22
ITMI952614A0 (en) 1995-12-13
GB9426075D0 (en) 1995-02-22
JPH08231581A (en) 1996-09-10
JP4081148B2 (en) 2008-04-23
ITMI952614A1 (en) 1997-06-13
GB2296495A (en) 1996-07-03
IT1277073B1 (en) 1997-11-04

Similar Documents

Publication Publication Date Title
ZA952413B (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
GB9511077D0 (en) 17B-Substituted-6-azasteroid derivatives
EP0708091A3 (en) Indoloylguanidine derivatives
ZA953356B (en) Benzocycloalkylazolethione derivatives
EP0747348A4 (en) Aminoalkylcyclopropane derivative
EP0692482A3 (en) 1-pyridyltetrazolinone derivatives
GB2315067B (en) Morpholinyl anthracycline derivatives
GB2296495B (en) Anthracycline derivatives
GB2295614B (en) Novel 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives
IL116456A0 (en) Oligonucleotide-dendrimer conjugates
IL112519A0 (en) 5-heteroarylindole derivatives
IL113604A0 (en) Novel dialkoxy-pyridinyl-benzimidazole derivatives
HU9503339D0 (en) Amino-cyclopentane derivative
ZA973892B (en) Carbohydrate derivatives
HU9503582D0 (en) Thienopyridon derivatives
GB9511365D0 (en) Pyridazino-indole derivatives
AU1454895A (en) Diphenyloxazoline derivatives
GB9414308D0 (en) Advance mechanism
AU1385595A (en) Aryl-5-methylene-oxazole derivatives
GB2291425B (en) 7-Diazo-beta-lactam derivatives
GB2287463B (en) Bis-anthracycline derivatives
AU1385695A (en) Phenylthio-oxazoline derivatives
GB9410986D0 (en) Imidazopiperidine derivatives
GB9421893D0 (en) Benzofuranylimidazoline derivatives
GB9410120D0 (en) Oxodihydroindolylidene derivatives

Legal Events

Date Code Title Description
730A Proceeding under section 30 patents act 1977
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Expiry date: 20141222